Suchergebnisse - "Liu, Yalan"

PubPharm (13)

1

Medication adjustment of afatinib and combination therapy with sitagliptin for alleviating afatinib-induced diarrhea in rats

enthalten in: Neoplasia (New York, N.Y.) | 2023

von Zhang, L. | Hu, A. | Wang, Y. | +5

2

A non-coding variant in 5' untranslated region drove up-regulation of pseudo-kinase EPHA10 and caused non-syndromic hearing loss in humans

enthalten in: Human molecular genetics | 2023

von Huang, S. | Ma, L. | Liu, X. | +8

3

Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer : a prospective multicenter clinical trial from China

enthalten in: Diagnostic pathology | 2022

von Xu, C. | Sun, M. | Jin, M. | +11

4

HER2 promotes epithelial-mesenchymal transition through regulating osteopontin in gastric cancer

enthalten in: Pathology, research and practice | 2021

von Liu, Y. | Chen, L. | Jiang, D. | +4

5

Colorectal Adenocarcinomas Harboring ALK Fusion Genes : A Clinicopathologic and Molecular Genetic Study of 12 Cases and Review of the Literature

enthalten in: The American journal of surgical pathology | 2020

von Lasota, J. | Chłopek, M. | Wasąg, B. | +36

6

Late stage gastric cancer patients with extra gained HER2 positivity by dual block assessment may not show compromised efficacy to trastuzumab treatment

enthalten in: Aging | 2019

von Xu, C. | Liu, Y. | Jiang, D. | +9

7

Targeted deletion of c-Met in thymic epithelial cells leads to an autoimmune phenotype

enthalten in: Immunology and cell biology | 2018

von Su, M. | Hu, R. | Song, Y. | +2

8

HER2 assessment in locally advanced gastric cancer : comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks

enthalten in: Histopathology | 2017

von Xu, C. | Liu, Y. | Jiang, D. | +12

9

Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer

enthalten in: Diagnostic pathology | 2017

von Xu, C. | Liu, Y. | Ge, X. | +9

10

Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type

enthalten in: Oncotarget | 2017

von Xu, C. | Liu, Y. | Jiang, D. | +10